Cargando…

Prolonged Anaphylaxis to Pfizer Coronavirus Disease 2019 Vaccine: A Case Report and Mechanism of Action

BACKGROUND: In response to the devastating effects of the coronavirus disease 2019 pandemic, several vaccine prototypes have been developed, with the Pfizer/BioNTech (BNT162b2) platform being the first to receive emergency use authorization. Although taken to market on an unprecedented timeline, the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Frank, Ashleigh, Radparvar, Sara, Manasia, Anthony, Bassily-Marcus, Adel, Kohli-Seth, Roopa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8021358/ https://www.ncbi.nlm.nih.gov/pubmed/33834172 http://dx.doi.org/10.1097/CCE.0000000000000397

Ejemplares similares

Tracheostomy for Coronavirus Disease 2019 Patients: Maintaining the Standard of Care
por: Bassily-Marcus, Adel, et al.
Publicado: (2020)

Ludwig's angina complicated by fatal cervicofascial and mediastinal necrotizing fasciitis
por: Manasia, Anthony, et al.
Publicado: (2016)

Pulmonary Hypertension in Pregnancy: Critical Care Management
por: Bassily-Marcus, Adel M., et al.
Publicado: (2012)

Critical care management and intensive care unit outcomes following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy
por: Kapoor, Sumit, et al.
Publicado: (2017)

Timing of Intubation and In-Hospital Mortality in Patients With Coronavirus Disease 2019
por: Hyman, Jaime B., et al.
Publicado: (2020)

TRACHEOSTOMY TIMING AND OUTCOMES IN PATIENTS WITH COVID-19 PNEUMONIA
por: Illuzzi, Ella, et al.
Publicado: (2020)

Pfizer-BioNTech COVID-19 vaccine-related risk of anaphylaxis
Publicado: (2021)

Covid-19-vaccine-pfizer-biontech: Biphasic anaphylaxis: case report
Publicado: (2021)

Covid-19-vaccine-pfizer-biontech: Biphasic anaphylaxis: case report
Publicado: (2021)

Anaphylaxis after Pfizer-BioNTech COVID-19 vaccine in Japan
Publicado: (2021)

COVID-19-Vaccine-Pfizer-BioNTech: Anaphylaxis: case report
Publicado: (2022)

COVID-19-vaccine-Pfizer-BioNTech: Anaphylaxis: 21 case reports
Publicado: (2021)

Evaluation of anaphylaxis risk by skin testing with coronavirus disease 2019 messenger RNA vaccines on patients with anaphylaxis
por: Pienkowski, Marek M., et al.
Publicado: (2022)

COVID-19-Vaccine-Pfizer-BioNTech: Anaphylaxis to excipient polyethylene glycol: case report
Publicado: (2021)

Covid-19-vaccine-pfizer-biontech/elasomeran: Anaphylaxis and skin reaction: 2 case reports
Publicado: (2022)

Delayed-onset anaphylaxis after first dose of Pfizer-BioNTech COVID-19 vaccine
por: Tay, Carol, et al.
Publicado: (2022)

Pseudo-Anaphylactic Reactions to Pfizer BNT162b2 Vaccine: Report of 3 Cases of Anaphylaxis Post Pfizer BNT162b2 Vaccination
por: Lim, Xin Rong, et al.
Publicado: (2021)

Portal vein thrombosis after second Pfizer/BioNTech coronavirus disease 2019 vaccine
por: Petrochko, Jameson M., et al.
Publicado: (2022)

Comparing Seasonal Trends in Coronavirus Disease 2019 Patient Data at a Quaternary Hospital in New York City
por: Tandon, Pranai, et al.
Publicado: (2021)

Prolonged angioedema after Pfizer-BioNTech COVID-19 vaccine
por: Muhamad Fauzi, Siti Mardhiah
Publicado: (2023)

Recurring Weakness in Rhabdomyolysis Following Pfizer–BioNTech Coronavirus Disease 2019 mRNA Vaccination
por: Kimura, Motoya, et al.
Publicado: (2022)

Immune parameters during anaphylaxis to messenger RNA coronavirus disease 2019 vaccines: Not the usual suspects?
por: de Chaisemartin, Luc, et al.
Publicado: (2022)

Herpetic anterior uveitis following Pfizer–BioNTech coronavirus disease 2019 vaccine: two case reports
por: Ortiz-Egea, José Manuel, et al.
Publicado: (2022)

Anaphylaxis to Pfizer/BioNTech mRNA COVID-19 Vaccine in a Patient With Clinically Confirmed PEG Allergy
por: McSweeney, Morgan D., et al.
Publicado: (2021)

A Case Report of Prolonged Anaphylaxis after COVID-19 Vaccine
por: Armstrong, Lisa, et al.
Publicado: (2021)

Anaphylaxis-related knowledge and concerns in Canadian families during the coronavirus disease 2019 pandemic
por: Gabrielli, Sofianne, et al.
Publicado: (2021)

Non–immunoglobulin E-mediated allergy associated with Pfizer-BioNTech coronavirus disease 2019 vaccine excipient polyethylene glycol
por: Jiang, Shirley Y., et al.
Publicado: (2021)

Reports of anaphylaxis after coronavirus disease 2019 vaccination, South Korea, 26 February to 30 April 2021
por: Lee, Eunju, et al.
Publicado: (2021)

M044 POLYETHYLENE GLYCOL ALLERGY TESTING AN ADOLESCENT WITH ANAPHYLAXIS TO PEG-ASPARAGINASE BEFORE ADMINISTERING PFIZER-BIONTECH COVID-19 VACCINE
por: Breidenbaugh, M.
Publicado: (2021)

Anaphylaxis in Brazil between 2011 and 2019
por: Tanno, Luciana Kase, et al.
Publicado: (2022)

Post-vaccination Adverse Reactions After Receiving the Pfizer-BioNTech Coronavirus Disease 2019 Vaccines Among Healthcare Workers in Sapporo, Japan
por: Shimamura, Yoshinosuke, et al.
Publicado: (2022)

Food anaphylaxis and augmentation factors – data of the German-speaking anaphylaxis registry
por: Hompes, Stephanie, et al.
Publicado: (2011)

Prolonged and Late-Onset Symptoms of Coronavirus Disease 2019
por: Miyazato, Yusuke, et al.
Publicado: (2020)

Coronavirus disease 2019 (COVID-19) and QTc prolongation
por: Changal, Khalid, et al.
Publicado: (2021)

Myopericarditis After the Pfizer Messenger Ribonucleic Acid Coronavirus Disease Vaccine in Adolescents
por: Schauer, Jenna, et al.
Publicado: (2021)

M013 SUCCESSFUL FOUR-STEP GRADED-DOSE ADMINISTRATION TO THE PFIZER-MRNA SARS-COV-2 VACCINE IN A PATIENT WITH PREVIOUS ANAPHYLAXIS
por: Morgenstern-Kaplan, D., et al.
Publicado: (2021)

Cumulative Adverse Event Reporting of Anaphylaxis After mRNA COVID-19 Vaccine (Pfizer-BioNTech) Injections in Japan: The First-Month Report
por: Iguchi, Toyotaka, et al.
Publicado: (2021)

Prolonged RNA shedding of the 2019 novel coronavirus in an asymptomatic patient with a VP shunt
por: El-Baba, Firas, et al.
Publicado: (2020)

How exciting is the Pfizer vaccine?
por: Lawton, Graham
Publicado: (2020)

A predictive model to estimate fever after receipt of the second dose of Pfizer‐BioNTech coronavirus disease 2019 vaccine: An observational cohort study
por: Chiba, Satoru, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_08au7o9nre6tnt1c67mpke0gmo